Europe — EMA
Oxomemazine Sans Sucre, Édulcorée À L'acésulfame Potassique Eg
GNH USA supplies Oxomemazine Sans Sucre (Oxomemazine), a first‑generation antihistamine for allergic rhinitis, urticaria and pruritic skin conditions.
Request sourcing
What is Oxomemazine?
Oxomemazine, the active ingredient in Oxomemazine Sans Sucre, Édulcorée À L'acésulfame Potassique Eg, is a first‑generation antihistamine presented as a oral formulation for systemic use. It is employed to relieve allergic symptoms such as itching, rash, and runny nose in children and adults.
GNH USA supplies Oxomemazine Sans Sucre, Édulcorée À L'acésulfame Potassique Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Oxomemazine used for?
Oxomemazine is a first‑generation H1‑receptor antagonist that reduces histamine‑mediated allergic responses. - Allergic rhinitis: alleviates nasal congestion, sneezing and itching. - Acute urticaria: reduces wheal formation and pruritus. - Pruritic skin conditions: eases itching associated with insect bites or mild dermatitis.
What are the side effects of Oxomemazine?
Oxomemazine may cause a range of adverse reactions, most of which are mild and reversible.
Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to a sticky sensation. - Dizziness: light‑headed feeling, especially when standing quickly. - Gastrointestinal discomfort: mild nausea or stomach upset. - Blurred vision: temporary difficulty focusing.
Serious or Rare Side Effects: - Cardiac arrhythmias: irregular heartbeat, particularly in patients with pre‑existing heart disease. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes indicating liver stress. - Hematologic abnormalities: rare cases of blood dyscrasias like agranulocytosis.
What precautions apply to Oxomemazine?
Before using Oxomemazine, consider the following safety measures: - Pregnancy: avoid unless clearly needed, as safety data are limited. - Breastfeeding: discontinue if infant shows signs of sedation or irritability. - Elderly patients: start with the lowest effective dose due to increased sensitivity to sedation. - Concomitant CNS depressants: monitor for enhanced drowsiness or respiratory depression. - Driving and machinery: avoid operating vehicles or heavy equipment until individual response is known. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.
What does Oxomemazine interact with?
Oxomemazine can interact with several drug classes; awareness helps prevent adverse outcomes.
Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis and exaggerated anticholinergic effects. - Other sedating antihistamines or CNS depressants: may cause profound sedation or respiratory depression.
Moderate Interactions (Monitor Closely): - Alcohol: can increase drowsiness and impair coordination. - Anticholinergic agents: may intensify dry mouth, urinary retention, or constipation. - CYP2D6 substrates: oxomemazine may alter plasma levels of drugs metabolised by this pathway.
